Cargando…
Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times
BACKGROUND: Patients have difficult unmet needs when standard chemotherapy produces a median survival of less than 1 year or many patients will experience severe toxicities. Blood tests can predict their survival. METHODS: Analyses evaluate predictive blood tests to identify patients who often survi...
Autores principales: | Bruckner, Howard W., Bassali, Fred, Dusowitz, Elisheva, Gurell, Daniel, Book, Abe, De Jager, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629612/ https://www.ncbi.nlm.nih.gov/pubmed/36322580 http://dx.doi.org/10.1371/journal.pone.0276492 |
Ejemplares similares
-
Testing the effect of historical representations on collective identity and action
por: Makanju, Damilola, et al.
Publicado: (2020) -
Comparing survival curves based on medians
por: Chen, Zhongxue, et al.
Publicado: (2016) -
Assessment of Median and Mean Survival Time in Cancer Clinical Trials
por: Das, Ananya, et al.
Publicado: (2023) -
A nonparametric test for equality of survival medians using right-censored prevalent cohort survival data
por: McVittie, James Hugh, et al.
Publicado: (2022) -
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
por: Ellingson, Benjamin M, et al.
Publicado: (2023)